Expert Recommendations in Relapsed/Refractory Multiple Myeloma

In this on demand webcast, expert faculty discuss best practices in treating patients
with relapsed/refractory multiple myeloma. 

Myeloma News

Keep up to date on the latest multiple myeloma news and information.

Myeloma News

Recent Publications

A five-year follow-up clinical study of the B cell maturation antigen chimeric antigen receptor-T cell therapy HDS269B in patients with relapsed or refractory multiple myeloma

Clin Cancer Res. 2024 Jun 13. doi: 10.1158/1078-0432.CCR-24-0414. Online ahead of print. ABSTRACT PURPOSE: This study aimed to report the five-year clinical outcomes of anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) therapy in relapsed/refractory multiple...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.